UNITED THERAPEUTICS Corp
▲ 1 upgrades / ▼ 0 downgrades / 4 reiterations from 4 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Oct 19, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Oct 7, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 1, 2026 | BTIG | upgrade | Neutral → Buy | — | 52% |
| Sep 24, 2026 | Goldman Sachs | initiate | — → Sell | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 23, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Jul 10, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 7, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | — | 54% |
| Apr 10, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 31, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 31, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 31, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Mar 30, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Mar 23, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 12, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Mar 5, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Feb 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $600 | 44% |
| Feb 26, 2026 | TD Cowen | maintain | Buy → Buy | $575 | 54% |
| Feb 26, 2026 | Oppenheimer | maintain | Outperform → Outperform | $600 | 52% |
| Feb 26, 2026 | RBC Capital | maintain | Outperform → Outperform | $643 | 55% |
| Feb 26, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $466 | 54% |
| Jan 6, 2026 | UBS | maintain | Buy → Buy | $645 | 54% |
| Nov 6, 2025 | UBS | maintain | Buy → Buy | $600 | 54% |
| Oct 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $525 | 44% |
| Oct 30, 2025 | RBC Capital | maintain | Outperform → Outperform | $587 | 55% |
| Oct 30, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $423 | 54% |
| Oct 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $435 | 54% |
| Sep 29, 2025 | UBS | maintain | Buy → Buy | $580 | 54% |
| Sep 26, 2025 | RBC Capital | initiate | — → Outperform | $569 | 55% |
| Sep 10, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $525 | 50% |
| Sep 5, 2025 | Oppenheimer | maintain | Outperform → Outperform | $575 | 52% |
| Sep 5, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $500 | 44% |
| Sep 4, 2025 | UBS | maintain | Buy → Buy | $560 | 54% |
| Sep 3, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $414 | 54% |
| Sep 2, 2025 | Jefferies | maintain | Buy → Buy | $564 | 52% |
| Sep 2, 2025 | B of A Securities | maintain | Neutral → Neutral | $463 | 53% |
| Aug 13, 2025 | UBS | maintain | Buy → Buy | $415 | 54% |
| Jul 31, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $295 | 54% |
| Jul 31, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $400 | 44% |
| Jul 10, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $328 | 54% |
| Jul 8, 2025 | JP Morgan | maintain | Overweight → Overweight | $330 | 55% |
| Jun 30, 2025 | UBS | maintain | Buy → Buy | $385 | 54% |
| Jun 11, 2025 | B of A Securities | maintain | Neutral → Neutral | $315 | 53% |
| Jun 2, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $405 | 50% |
| May 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $425 | 44% |
| May 1, 2025 | JP Morgan | maintain | Overweight → Overweight | $350 | 55% |
No cross-platform signals in the last 90 days